Stay updated on STORM Clinical Trial - Selinexor in Refractory Myeloma
Sign up to get notified when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.

Latest updates to the STORM Clinical Trial - Selinexor in Refractory Myeloma page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check26 days agoChange DetectedA banner announces that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.4%

- Check33 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check40 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check61 days agoChange DetectedA new Revision: v3.7.0 entry was added to the study record history, updating the version history. The previous Revision: v3.6.6 entry was removed.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page's revision history shows a new entry: Revision: v3.6.6. The previous revision, v3.6.5, was removed, indicating a minor site update to the study record history.SummaryDifference0.1%

Stay in the know with updates to STORM Clinical Trial - Selinexor in Refractory Myeloma
Enter your email address, and we'll notify you when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.